Ihuman Accounts Payable vs Non Current Assets Total Analysis

IH Stock  USD 2.00  0.01  0.50%   
Ihuman financial indicator trend analysis is infinitely more than just investigating Ihuman Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ihuman Inc is a good investment. Please check the relationship between Ihuman Accounts Payable and its Non Current Assets Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Accounts Payable vs Non Current Assets Total

Accounts Payable vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ihuman Inc Accounts Payable account and Non Current Assets Total. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Ihuman's Accounts Payable and Non Current Assets Total is 0.95. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Ihuman Inc, assuming nothing else is changed. The correlation between historical values of Ihuman's Accounts Payable and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Ihuman Inc are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Accounts Payable i.e., Ihuman's Accounts Payable and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.95
Relationship DirectionPositive 
Relationship StrengthVery Strong

Accounts Payable

An accounting item on the balance sheet that represents Ihuman obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ihuman Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from Ihuman's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ihuman Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
As of now, Ihuman's Enterprise Value Multiple is increasing as compared to previous years.
 2021 2022 2023 2024 (projected)
Gross Profit660.6M691.2M721.3M483.8M
Total Revenue944.7M985.5M1.0B702.3M

Ihuman fundamental ratios Correlations

0.790.991.00.970.730.99-0.98-0.650.91.00.940.870.861.00.970.950.870.99-0.810.730.980.991.01.00.96
0.790.760.790.790.570.77-0.76-0.20.80.780.780.650.640.780.730.580.760.74-0.40.620.690.760.790.790.59
0.990.760.980.950.791.0-0.97-0.710.920.980.960.890.890.980.970.940.890.98-0.780.780.981.00.980.990.95
1.00.790.980.960.690.98-0.98-0.620.881.00.920.860.851.00.960.950.860.99-0.820.690.970.981.01.00.95
0.970.790.950.960.740.96-0.98-0.60.920.970.890.790.780.970.950.90.850.96-0.790.680.960.960.960.970.92
0.730.570.790.690.740.77-0.69-0.740.930.710.870.760.80.710.710.680.730.75-0.340.750.780.790.690.710.69
0.990.771.00.980.960.77-0.97-0.710.920.990.950.860.870.990.980.940.870.98-0.80.790.981.00.980.990.95
-0.98-0.76-0.97-0.98-0.98-0.69-0.970.59-0.88-0.98-0.9-0.85-0.82-0.98-0.95-0.93-0.9-0.960.85-0.63-0.96-0.97-0.98-0.98-0.95
-0.65-0.2-0.71-0.62-0.6-0.74-0.710.59-0.67-0.65-0.64-0.55-0.6-0.65-0.73-0.76-0.41-0.720.59-0.78-0.77-0.71-0.62-0.65-0.73
0.90.80.920.880.920.930.92-0.88-0.670.890.950.830.840.890.880.810.840.91-0.540.780.910.930.880.90.82
1.00.780.981.00.970.710.99-0.98-0.650.890.920.870.851.00.960.960.860.99-0.820.710.980.981.01.00.96
0.940.780.960.920.890.870.95-0.9-0.640.950.920.950.960.920.870.870.940.92-0.610.750.910.960.920.930.88
0.870.650.890.860.790.760.86-0.85-0.550.830.870.950.990.870.740.870.940.85-0.620.540.840.890.860.860.87
0.860.640.890.850.780.80.87-0.82-0.60.840.850.960.990.850.750.860.920.85-0.580.60.840.890.850.850.86
1.00.780.981.00.970.710.99-0.98-0.650.891.00.920.870.850.960.960.860.99-0.820.710.980.981.01.00.96
0.970.730.970.960.950.710.98-0.95-0.730.880.960.870.740.750.960.920.770.97-0.830.820.980.970.960.970.92
0.950.580.940.950.90.680.94-0.93-0.760.810.960.870.870.860.960.920.790.97-0.870.640.970.940.950.960.99
0.870.760.890.860.850.730.87-0.9-0.410.840.860.940.940.920.860.770.790.83-0.630.520.820.890.860.860.83
0.990.740.980.990.960.750.98-0.96-0.720.910.990.920.850.850.990.970.970.83-0.810.740.990.980.990.990.97
-0.81-0.4-0.78-0.82-0.79-0.34-0.80.850.59-0.54-0.82-0.61-0.62-0.58-0.82-0.83-0.87-0.63-0.81-0.44-0.83-0.78-0.82-0.82-0.89
0.730.620.780.690.680.750.79-0.63-0.780.780.710.750.540.60.710.820.640.520.74-0.440.760.790.690.720.61
0.980.690.980.970.960.780.98-0.96-0.770.910.980.910.840.840.980.980.970.820.99-0.830.760.980.970.980.97
0.990.761.00.980.960.791.0-0.97-0.710.930.980.960.890.890.980.970.940.890.98-0.780.790.980.980.990.95
1.00.790.981.00.960.690.98-0.98-0.620.881.00.920.860.851.00.960.950.860.99-0.820.690.970.981.00.95
1.00.790.991.00.970.710.99-0.98-0.650.91.00.930.860.851.00.970.960.860.99-0.820.720.980.991.00.96
0.960.590.950.950.920.690.95-0.95-0.730.820.960.880.870.860.960.920.990.830.97-0.890.610.970.950.950.96
Click cells to compare fundamentals

Ihuman Account Relationship Matchups

Ihuman fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets168.3M1.0B1.1B1.3B1.5B945.7M
Other Current Liab880K107.5M124.7M151.7M148.1M112.2M
Total Current Liabilities182.8M399.2M482.9M561.1M490.8M410.5M
Total Stockholder Equity(14.4M)642.7M608.4M769.5M957.8M531.7M
Property Plant And Equipment Net2.5M12.9M50.5M22.0M9.8M18.0M
Current Deferred Revenue71.8M268.6M303.0M379.1M318.6M251.0M
Net Debt(104.9M)(855.1M)(821.1M)(1.0B)(1.2B)(1.1B)
Retained Earnings(348.5M)(386.0M)(423.0M)(321.2M)(140.5M)(147.5M)
Accounts Payable10.3M21.6M30.5M24.2M22.1M22.3M
Cash104.9M861.7M855.4M1.0B1.2B750.2M
Non Current Assets Total5.3M25.5M85.6M79.6M68.1M48.6M
Non Currrent Assets Other2.7M784K7.8M6.4M8.7M4.9M
Other Assets2.7M784K7.8M6.4M7.4M4.0M
Cash And Short Term Investments104.9M861.7M855.4M1.0B1.2B750.2M
Net Receivables21.0M78.3M59.0M81.9M62.6M58.0M
Liabilities And Stockholders Equity168.3M1.0B1.1B1.3B1.5B945.7M
Non Current Liabilities Total82.1M5.1M9.6M2.9M1.9M1.8M
Capital Surpluse213.1M1.1B1.1B1.1B1.2B751.9M
Inventory20.7M16.9M28.1M19.1M16.5M17.4M
Other Current Assets574K64.6M72.9M102.8M8.1M7.7M
Other Stockholder Equity333.9M1.1B1.1B1.1B1.1B844.0M
Total Liab182.8M404.3M492.5M563.9M492.7M414.1M
Net Invested Capital(14.4M)642.7M608.4M769.5M957.8M531.7M
Total Current Assets163.1M1.0B1.0B1.3B1.4B897.1M
Accumulated Other Comprehensive Income0.0(21.9M)(34.7M)18.5M26.1M27.4M
Cash And Equivalents104.9M861.7M855.4M1.0B1.2B633.2M
Net Working Capital(19.7M)622.2M532.3M692.7M891.7M486.6M
Short Term Debt99.8M1.5M24.7M6.1M1.9M1.8M
Intangible Assets103K11.8M27.3M24.9M23.2M16.0M
Property Plant Equipment2.5M12.9M50.5M22.0M25.3M19.5M

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Ihuman Stock

When determining whether Ihuman Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ihuman's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ihuman Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ihuman Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Earnings Share
0.46
Revenue Per Share
19.279
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0718
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.